Table 1. Summary of the clinical phenotype of the three affected patients with DMXL2 mutations (see Figure 1 for patient numbering).
Patient | #123 | #124 | #125 |
Age (years) | 21.4 | 20.3 | 16.8 |
Weight at birth g (SDS) | 2,700 (−2.2) | 2,810 (−0.9) | 3,060 (−1.1) |
Height at birth cm (SDS) | 46 (−2.5) | 47 (−1.1) | 49 (−0.8) |
Postnatal growth retardation | + | + | + |
Height cm (SDS) | 159 (−2.8) | 165 (−1.8) | 156 (−2.5) |
Body mass index kg/m2 (SDS) | 17.4 (−1.9) | 21.3 (−0.2) | 15.2 (−2.0) |
Head circumference, cm (SDS) | 54.5 (−1.9) | 56 (−0.8) | 51.5 (−2.5) |
Ataxia | + | + | + |
Dystonia | + | + | + |
Demyelinating sensorimotor polyneuropathy | + | + | + |
Pyramidal syndrome | + | + | + |
Motor delay | + | + | + |
Dysarthria | + | + | + |
Partial frontal alopecia | + | + | + |
Intellectual disability (moderate) | + | + | + |
White matter disease (moderate subcortical, temporal) | + | + | + |
Hypoglycemia during childhood (asymptomatic) | + | + | + |
Nonautoimmune insulin-dependent diabetes mellitus | + | + | + |
Hypogonadotropic hypogonadism | + | + | + |
Low testicular volume (normal values in young adults >12 ml) | 5 ml | 7 ml | 8 ml |
Central hypothyroidism | + | + | + |
Hypoplastic pituitary gland | + | − | − |
Other features | Progressive hearing loss |
SDS, standard deviation score.